Pharmaceutical & Medical Translation

To avoid delays in the review of product registration and to minimize the risk of rejection, it is critical for Chinese government officials to understand your data accurately. Translating your data with high accuracy from both pharmaceutical and linguistic perspectives can ensure a successful product registration.

BaiPharm provides translation services with linguistic professionals from pharmaceutical academies, delivering exceptional accuracy in pharmaceutical, non-clinical, and clinical medical terminology for regulatory submissions.

Why Choose BaiPharm?

BaiPharm, a specialized subsidiary of REACH24H Consulting Group, is dedicated to pharmaceutical regulatory compliance. With offices in the U.S., EU, Japan, and South Korea, our expert team — including regulatory specialists, GxP auditors, consultants, certified toxicologists, and former inspectors — has supported over 600 pharmaceutical firms from 26 countries.

Boasting solid expertise in pharmaceutical and medical translation, BaiPharm provides highly specialized linguistic support across regulatory submissions, ensuring exceptional accuracy in pharmaceutical, non-clinical, and clinical medical terminology.

Compared with general translation service providers, our regulatory background enables a deeper understanding of scientific and compliance contexts, resulting in more precise and submission-ready translations of technical dossiers, clinical study reports, and labeling materials. Our translation work is closely aligned with regulatory expectations and review practices in China, helping to reduce interpretation gaps, minimize compliance risks, and support smoother regulatory review and approval processes for international pharmaceutical companies entering the Chinese market.